Discovery of novel ansamycins possessing potent inhibitory activity in a cell-based oncostatin M signalling assay. (Q40854306)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Discovery of novel ansamycins possessing potent inhibitory activity in a cell-based oncostatin M signalling assay (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

[(4E,10E)-13,19,20-trihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3-oxo-2-azabicyclo[16.3.1]docosa-1(22),4,10,18,20-pentaen-9-yl] carbamate

1 reference

inferred from

reverse claim

[(4E,10E)-13,20-dihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3-oxo-2-azabicyclo[16.3.1]docosa-1(21),4,10,18(22),19-pentaen-9-yl] carbamate

1 reference

P Stead

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S Latif

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A P Blackaby

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

P J Sidebottom

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Deakin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

N L Taylor

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

P Life

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J Spaull

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

F Burrell

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

R Jones

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J Lewis

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

I Davidson

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

T Mander

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

10 November 2019

https://www.jstage.jst.go.jp/article/antibiotics1968/53/7/53_7_657/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.53.657?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

657-663

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.53.657?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.657

The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.657

Geldanamycin, a new antibiotic

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.657

Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.657

Identifiers

DOI

10.7164/ANTIBIOTICS.53.657

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994806%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference